Key Insights

Highlights

No notable highlights available yet

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

0.0%

0 terminated out of 6 trials

Late-Stage Pipeline

17%

1 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

6Total
Not Applicable (5)
P 4 (1)

Trial Status

Enrolling By Invitation3
Recruiting2
Unknown1

Clinical Trials (6)

Showing 6 of 6 trials
NCT07561528Phase 4Recruiting

Electrophysiological Biomarkers and Treatment Response to Accelerated Transcranial Magnetic Stimulation in Patients With Obsessive-Compulsive Disorder

NCT07176091Not ApplicableEnrolling By Invitation

Clinical Efficacy of Intermittent Theta Burst Transcranial Magnetic Stimulation With Different Modes on Parkinson's Disease

NCT07198438Not ApplicableEnrolling By InvitationPrimary

Deep Versus Standard Prolonged Intermittent Theta Burst Stimulation for Depression

NCT07264452Not ApplicableRecruiting

Comparison of the Efficacy of Accelerated Intermittent Theta Burst Stimulation and Accelerated Continuous Theta Burst Stimulation in Patients With Treatment-Resistant Depression

NCT06464835Not ApplicableEnrolling By Invitation

Effects of ITBS Combined with NMES on Dysphagia After Stroke

NCT05445505Not ApplicableUnknown

Neuroprotective Effects of iTBS in PD

Showing all 6 trials

Research Network

Activity Timeline